Olema Pharmaceuticals, Inc.
OLMA
Revenue
0.00
0.000.00%
-Assets
254.56M
▼-9.14M▼-3.47%
3 Months ChangeLiabilities
27.39M
▲18.00k▲0.06575%
3 Months ChangeFree Cash Flow
-23.65M
▼-5.72M▼-31.87%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-27
Form 8-K
ID: 0000950170-24-109753
2024-08-06
Form 10-Q
ID: 0000950170-24-091836
2024-08-06
Form 8-K
ID: 0000950170-24-091799
2024-07-02
Form 8-K
ID: 0000950170-24-080546
2024-06-14
Form 8-K
ID: 0000950170-24-073749
2024-05-15
Form 8-K
ID: 0000950170-24-060031
2024-05-08
Form 10-Q
ID: 0000950170-24-055686
2024-05-08
Form 8-K
ID: 0000950170-24-055630
2024-03-11
Form 8-K
ID: 0000950170-24-029221
2024-01-08
Form 8-K
ID: 0000950170-24-002741